Articles related to CLINICAL STUDY

The study suggests that although unlicensed doses may lead to additional symptom reduction, the gains are small and come with an increased risk of adverse events.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.

The study underscores the potential influence of pharmaceutical industry payments on the delivery of non-recommended or low value interventions in cancer treatment. It highlights the need for increased transparency and scrutiny in the financial relationships between physicians and the industry.

The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.

A recent study from Fox Chase Cancer Center has revealed that as many as 23% of cystic renal masses may carry high-grade, or aggressive, disease. This finding challenges the prevailing assumption of their low-risk nature and underscores the need for more discerning diagnostic and treatment strategies.

The study found that both primary care physicians and nurse practitioners averaged approximately 1.7 inappropriate prescriptions for every 100 prescriptions written. This finding underscores the shared challenge of inappropriate prescribing across healthcare professions.